Michael Shpigelmacher
Khosla joins bet on unconventional startup looking to send drug delivering robots into the brain
When Michael Shpigelmacher started the project, he knew he’d have to fund it himself. Every other effort of its kind was academic, rejected as too …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
